IPW
MRNS

Impact Partnership Wealth’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Impact Partnership Wealth’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-749
Closed -$6.03K – 1114
2023
Q3 		$6.03K Buy
+749
New +$6.23K ﹤0.01% 665

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Impact Partnership Wealth's MRNS Position: Q4 2023 in Review

Impact Partnership Wealth sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2023, closing a stake of 749 shares — an estimated $6.03K sold.

Impact Partnership Wealth first reported a position in MRNS in Q3 2023 and held it in 1 quarter. The position peaked at $6.03K in Q3 2023. 105 funds tracked by Wall St. Rank hold MRNS as of Q4 2023.

  • Impact Partnership Wealth reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 749 Marinus Pharmaceuticals, Inc shares in Q4 2023, an estimated $6.03K.
  • Impact Partnership Wealth first reported a position in Marinus Pharmaceuticals, Inc in Q3 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Marinus Pharmaceuticals, Inc position peaked at $6.03K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2023.

Based on Impact Partnership Wealth's 13F filing for Q4 2023, filed 14 Feb 2024.